Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02081989

Renal Denervation in Diabetes.

Effect of Renal Sympathetic Denervation on Glycemic Status Independent of Blood Pressure-lowering.

Status
Withdrawn
Phase
Phase 4
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Monash University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Renal denervation (the use of radio waves to oblate the renal artery) has been shown to be an effective treatment for high blood pressure. It is currently being tested in heart failure patients and we would now like to look it its effects on diabetes. We therefore plan to enrol 20 participants with type II diabetes into this study. Half will undergo renal denervation in addition to their standard care and the other half will act as controls and only receive standard care. Treatment allocation will be randomly assigned. All participants will undergo screening (including a physical exam, blood tests, ultrasounds and a muscle biopsy). All patients will have follow up tests (including physical exams and blood tests) 1, 3 and 6 months later.

Conditions

Interventions

TypeNameDescription
PROCEDURERenal denervationRenal denervation

Timeline

Start date
2015-11-01
Primary completion
2016-05-01
Completion
2016-05-01
First posted
2014-03-07
Last updated
2016-06-01

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT02081989. Inclusion in this directory is not an endorsement.